Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Vulvar Neoplasms × cemiplimab × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 42 Melanoma 19 Neoplasms 14 Neoplasm Metastasis 14 Squamous Cell Carcinoma of Head and Neck 13 Skin Neoplasms 11 Lung Neoplasms 10 Carcinoma, Squamous Cell 8 Carcinoma, Renal Cell 8 Head and Neck Neoplasms 7 Urinary Bladder Neoplasms 6 Recurrence 6 Ovarian Neoplasms 6 Colorectal Neoplasms 5 Carcinoma, Merkel Cell 5 Carcinoma, Basal Cell 5 Breast Neoplasms 5 Triple Negative Breast Neoplasms 4 Prostatic Neoplasms 4 Pancreatic Neoplasms 4 Multiple Myeloma 4 Colonic Neoplasms 4 Adenocarcinoma 4 Mycosis Fungoides 3 Glioblastoma 3 Fallopian Tube Neoplasms 3 Cutaneous Squamous Cell Carcinoma 3 Carcinoma, Hepatocellular 3 Carcinoma 3 Uveal Melanoma 2

Interventions

Radiotherapy 9 Cisplatin 8 pembrolizumab 5 Methods 5 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 5 Papillomavirus Vaccines 4 Brachytherapy 4 fludarabine 3 Vaccines, Synthetic 3 Vaccines 3 Surveys and Questionnaires 3 Sentinel Lymph Node Biopsy 3 Radiosurgery 3 Radiation 3 Platinum 3 Palliative Care 3 Nivolumab 3 Indocyanine Green 3 Gemcitabine 3 Early Intervention, Educational 3 Cyclophosphamide 3 Carboplatin 3 Bleomycin 3 Biopsy 3 1,2-diaminocyclohexaneplatinum II citrate 3 tremelimumab 2 lenvatinib 2 entinostat 2 durvalumab 2 aldesleukin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07101848 2025-08-03

BRAVA VULVAR

Hospital Israelita Albert Einstein

Phase 2 Not yet recruiting

Vulvar Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡